Article
A powerful drug combination strategy targeting glutamine addiction for the treatment of…
eLife · 2020 · Haojie Jin, author Siying Wang, author Esther A Zaal, author Cun Wang, author Haiqiu Wu, author Astrid Bosma, author Fleur Jochems, author Nikita Isima, author Guangzhi Jin, author Cor Lieftink, author Roderick Beijersbergen, author Celia R Berkers, author ([email protected]) Wenxin Qin, author ([email protected]) Rene Bernards, author ([email protected]) Matthew G Vander Heiden, editor Jonathan A Cooper, senior_editor
Key facts
| Title | A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer |
|---|---|
| First author | Haojie Jin, author Siying Wang, author Esther A Zaal, author Cun Wang, author Haiqiu Wu, author Astrid Bosma, author Fleur Jochems, author Nikita Isima, author Guangzhi Jin, author Cor Lieftink, author Roderick Beijersbergen, author Celia R Berkers, author ([email protected]) Wenxin Qin, author ([email protected]) Rene Bernards, author ([email protected]) Matthew G Vander Heiden, editor Jonathan A Cooper, senior_editor |
| Journal | eLife |
| Published | Oct 5, 2020 |
| DOI | 10.7554/eLife.56749 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIT, LXG, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1